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Abstract
Deregulated translation plays an important role in human cancer. We previously reported decreased eukaryotic initiation
factor 3 subunit f (eIF3f) expression in pancreatic cancer. Whether decreased eIF3f expression can transform normal
epithelial cells is not known. In our current study, we found evidence that stable knockdown of eIF3f in normal human
pancreatic ductal epithelial cells increased cell size, nuclear pleomorphism, cytokinesis defects, cell proliferation,
clonogenicity, apoptotic resistance, migration, and formation of 3-dimensional irregular masses. Our findings support the
tumor suppressive role of eIF3f in pancreatic cancer. Mechanistically, we found that eIF3f inhibited both cap-dependent and
cap-independent translation. An increase in the ribosomal RNA (rRNA) level was suggested to promote the generation of
cancer. The regulatory mechanism of rRNA degradation in mammals is not well understood. We demonstrated here that
eIF3f promotes rRNA degradation through direct interaction with heterogeneous nuclear ribonucleoprotein (hnRNP) K. We
showed that hnRNP K is required for maintaining rRNA stability: under stress conditions, eIF3f dissociates hnRNP K from
rRNA, thereby preventing it from protecting rRNA from degradation. We also demonstrated that rRNA degradation occurred
in non-P body, non-stress granule cytoplasmic foci that contain eIF3f. Our findings established a new mechanism of rRNA
decay regulation mediated by hnRNP K/eIF3f and suggest that the tumor suppressive function of eIF3f may link to impaired
rRNA degradation and translation.
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Introduction
Deregulated translation plays an important role in human
cancer [1]. The translation process can be divided into 4 phases:
initiation, elongation, termination, and ribosome recycling [2].
Translation is mostly regulated at the initiation phase. Eukaryotic
initiation factor (eIF) 3 plays a central role in translation initiation.
Mammalian eIF3, the largest of the initiation factors, exists as a
protein complex with at least 13 nonidentical subunits (eIF3a-m)
[3]. The functions of the individual subunits have not yet been
fully defined in mammals. Altering the expression level or the
function of eIF3 may influence the synthesis of some proteins and
consequently cause abnormal cell growth and malignant transfor-
mation. Seven eIF3 subunits have been implicated in human
cancer [4,5,6]. Recent studies indicate that individual overexpres-
sion of 5 subunits of eIF3 promotes malignant transformation of
NIH3T3 cells [7]. Therefore, deregulation of eIF3 subunits can
contribute to tumorigenesis via induction of protein synthesis.
However, how these eIF3 subunits contribute to tumorigenesis is
still unclear.
The function of eIF3f, a non-core eIF3 subunit, is not well
understood. Previously, we identified eIF3f as a protein involved in
apoptotic signaling [8]. We demonstrated that eIF3f expression
significantly decreased in many human cancers [6,9,10]. We also
showed that restored eIF3f expression in tumor cells causes
ribosomal RNA (rRNA) degradation, inhibits translation and cell
proliferation, and induces apoptosis [6]. Those results represented
the first demonstration that eIF3f contributes to tumorigenesis.
rRNA is an essential structural and catalytic component of
ribosome. An increase in the rRNA level might promote the
generation of cancer [11]. The homeostasis of the rRNA level
must be maintained for normal cellular function and under stress
conditions. Cells need to keep a balance between rRNA
generation and degradation. The regulatory mechanism of rRNA
degradation in mammals is not well understood. We previously
showed that eIF3f might contribute to rRNA degradation [6].
However, the underlying molecular mechanism is not clear.
The heterogeneous nuclear ribonucleoprotein (hnRNP) K, an
essential RNA and DNA binding protein, is a component of the
hnRNP complex. We previously showed that hnRNP K is also
involved in tumorigenesis [12,13]. It is known that hnRNP K
stabilizes RNA by binding to the 39 UTR of the mRNA [14].
Yeast 3-hybrid screens and RNA pull-down assays indicated that
hnRNP K binds to 18S and 25S rRNA in yeast [15]. However,
whether hnRNP K regulates rRNA stability in humans is
unknown.
In our current study, we tested the hypothesis that eIF3f
coordinates with hnRNP K to regulate rRNA degradation and
that decreased eIF3f expression contributes to tumorigenesis by
deregulating translation and apoptosis. We demonstrated that
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e34194eIF3f directly interacts with hnRNP K. Under stress conditions,
eIF3f dissociates hnRNP K from rRNA, thereby preventing it
from protecting rRNA from degradation. We showed that rRNA
degradation occurs in non-P body, non-stress granule cytoplasmic
foci. We also showed that silencing of eIF3f promotes both cap-
dependent and cap-independent/internal ribosome entry site
(IRES)-dependent translation and cytokinesis defects. Our findings
establish the physiologic role of eIF3f in rRNA degradation and
translation, and suggest that the tumor suppressive function of
eIF3f may link to impaired rRNA degradation and translation.
Materials and Methods
Ethics Statement
The use of human pancreatic cancer tissues in this study was
approved by the University of Arizona institutional review board.
Archival formalin fixed paraffin embedded tissues stored in the
Gastrointestinal Specialized Programs of Research Excellence (GI
SPORE) Tissue Bank and Department of Pathology were used.
Written informed consent from all participants involved in the
study was obtained by the tissue bank.
Cell culture and tissue specimens
We obtained BxPc3 and MiaPaCa-2 human pancreatic cancer
cell lines from American Type Culture Collection (ATCC,
Manassas, VA). The cells were cultured at 37uC with 5% CO2
in RPMI 1640 medium (Mediatech, Inc., Herndon, VA),
supplemented with 10% fetal bovine serum (Omega Scientific,
Inc, Tarzana, CA); 2.5 mg/ml glucose; 1% L-glutamine; and 1%
penicillin/streptomycin (Invitrogen, Carlsbad, CA). Immortalized
normal human pancreatic ductal epithelial (HPDE) cells and
Kras
G12D HPDE cells were kindly provided by Dr. Ming-Sound
Tsao, University of Toronto, Canada [16]. HPDE cells were
cultured in keratinocyte serum-free medium supplemented with
epidermal growth factor and bovine pituitary extract (Invitrogen).
We also obtained primary human foreskin fibroblast (HFF)-1 cells
from ATCC. The cells were cultured at 37uC with 5% CO2 in
Dulbecco’s Modified Eagle’s Medium with 15% fetal bovine
serum. All transfections were carried out using LipofectAMINE
2000 (Invitrogen) according to the manufacturer’s instructions.
Tissue specimens were obtained from the GI SPORE tissue bank
in the Department of Pathology at the University of Arizona; our
protocol was approved by the Human Subjects Committee of the
University of Arizona.
Construction of plasmids
We constructed pGEX-eIF3f and 4 pGEX-eIF3f deletion
constructs as previously described [8]. By cloning full-length eIF3f
into expression vector pcDNA3 (Invitrogen), using EcoRI and
XhoI restriction sites, we constructed pcDNA3-eIF3f. pCMV-HA-
eIF3f was constructed by cloning full-length eIF3f into expression
vector pCMV-HA (Clontech Laboratories, Mountain View, CA),
using EcoRI and XhoI restriction sites.
Purification of recombinant protein and GST pull-down
assay
Purification of recombinant protein and the glutathione S-
transferase (GST) pull-down assay was performed as previously
described by our group [8]. Briefly,
35S-labeled in vitro transcribed
and translated hnRNP K was incubated with GST, with full length
eIF3f, or with 4 deletion mutants of eIF3f. Then the bound
hnRNP K was separated by SDS-PAGE and visualized by
autoradiography. To examine the loading of the GST fusion
proteins, the gel was also stained with coomassie blue.
Immunofluorescence and molecular beacon analysis
Immunofluorescence analysis was performed as previously
described by our group [8]. To trigger oxidative stress and induce
P-body and stress granule formation, we used 0.5 mM sodium
arsenite. In some cases, we stained nuclei with mounting medium
with 49,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories,
Burlingame, CA). Rabbit Rck antibody was kindly provided by
Dr. Roy Parker. Rabbit polyclonal Dcp1a antibody was kindly
provided by Dr. Jens Lykke-Andersen. eIF4G antibody was
purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Goat eIF3f antibody was generated by our group as previously
described [8]. The specificity of the eIF3f antibody was well
proved by our previous publications, collaboration and sharing
with other investigators [6,8,17]. hnRNP K antibody was
purchased from Sigma-Aldrich (St. Louis, MO). Secondary
fluorescein isothiocyanate (FITC)-tagged anti-goat, Texas Red -
tagged anti-rabbit or anti-mouse antibody was purchased from
Jackson ImmunoResearch (West Grove, PA) and a 1:100 dilution
was used. For Rck and Dcp1a antibody, we used a 1:200 dilution;
for hnRNP K antibody, a 1:100 dilution; and for eIF4G and eIF3f
antibody, a 1:50 dilution.
To detect endogenous rRNA in cells, we used molecular beacons
that are complementary to 18S or 28S rRNA sequences. Molecular
beacons are reporter oligo molecules that contain a fluorophore on
one end and a quencher on the other end with a short stem-loop
structure [18]. This prevents these molecules from generating
fluorescence until they hybridize with their target RNA. Thus
molecular beacon improves signal to noise ratio and specificity. We
purchased Carboxyfluorescein (FAM)-tagged high-performance
liquid chromatography (HPLC)-purified molecular beacons from,
and designed by, Sigma-Aldrich: 28S rRNA: 59CGCGATCAG-
CAGGATTACCATGGCAACGA TCGCG [BHQ1] 39 and 18S
rRNA: 59 CGCGATCACCAACTAAGAACGGCCATGCAGA-
TCG CG [BHQ1] 39. Before we performed our immunofluores-
cence studies, cells were fixed and incubated with 200 nM of
molecular beacon at 37uC for 1 hour as described [19]. FITC, Cy3,
and Rhodamine Red or Texas-Red-tagged secondary antibody was
used. P-body-positive cells were counted in a total of at least 300
cells.
RIP-RT-PCR assay
We used a modified method described by Evans et al. [20].
Briefly, cells were incubated in 10 ml of medium containing 1%
(V/V) formaldehyde for 10 minutes at room temperature. To
quench the reaction, we added 0.25 M glycine. Then, we
harvested the cells; resuspended the pellet in radioimmunoprecip-
itation assay (RIPA) buffer (50 mM Tris-Cl pH 7.5, 1% NP40,
0.5% sodium deoxycholate, 0.05% SDS, 1 mM EDTA, 150 mM
NaCl); and sonicated the pellet to lyse the cells. Insoluble material
was removed by centrifugation and the lysates were precleared by
incubating them with protein G beads, mouse IgG, and yeast
tRNA (100 ug/ml). Next, the samples were centrifuged and the
proteins were immunoprecipitated from the supernatant overnight
at 4uC by adding hnRNP K or mouse IgG control antibodies and
protein G beads. Same volume of the sample was put aside as total
input without immunoprecipitation. The beads were harvested
and washed 6 times in RIPA buffer, additionally containing 0.5 M
NaCl and 1 M urea. Finally, the beads were resuspended in 100 ul
of 100 mM NaCl and 1% SDS to elute RNA. Then, the RNA
from the elution and from the total input was extracted using
phenol/chloroform/isopropanol (24:25:1). Total input and pre-
cipitated RNA was isolated and treated with DNase to eliminate
DNA contamination. We either reverse-transcribed RNA or, for a
negative control, did not; then, we performed polymerase chain
eIF3f and hnRNP K Regulate rRNA Stability
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primers. Immunoprecipitated rRNA was normalized against total
input rRNA.
Bicistronic luciferase reporter assay
Bicistronic luciferase reporter constructs were kindly provided by
Dr. Davide Ruggero (University of California, San Francisco). To
determine the linear range of luciferase production in the
transfection of the bicistronic luciferase constructs, we performed
a time course study and a dose response study. A range between 25
and 100 ng plasmids was determined to be linear (data not shown).
We used 70 nanograms of the individual construct to transfect into
eIF3f-silenced or control HPDE cells in 24-well plates in triplicate.
After 24 hours, cells were lysed in passive lysis buffer (Promega,
Madison, WI); the luciferase activity was measured according to the
manufacturer’s instructions for a dual-luciferase assay (Promega).
Actinomycin D chase analysis
We seeded cells at about 30% confluence in 6-well plates for
24 hours, and then treated them with actinomycin D (0.5 mg/ml)
to inhibit de novo transcription as described [21]. At the indicated
time point, cells were harvested. Total RNA was isolated and
treated with DNase before real time RT-PCR analysis was
performed.
Quantitative real-time RT-PCR
Total RNA was extracted using RNeasy Mini Kit (QIAGEN,
Valencia, CA) and treated with DNase. Real-time RT-PCR was
performed using iQ SYBRH Green Supermix Reagents (Bio-Rad,
Hercules, CA) and amplified in a 480 Lightcycler system
according to the manufacturer’s instructions (Roche, Basel,
Switzerland). Melting curve was used to determine the specificity
of the PCR products. We used these primers: 18S rRNA-forward
59-CTGCCCTATCAACTTTCGATGGTAG-39, reverse 59-CC-
GTTTCTCAGGCTCCCTCTC-39; and 28S rRNA-forward 59-
TGTCGGCTCTTCCTATCATTGT-39, reverse 59-ACCCAG-
CTCACGTTC CCT ATTA-39 as described previously [22]. We
have tested different reference genes, such as Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), b-actin, and RPL32. We
chose GAPDH as the reference gene because it is very stable and
comparable between cell lines, and it maintains a high expression
level (data not shown). eIF3f, hnRNP K and GAPDH primers
were previously described [6,23]. The conventional DDCt method
was used to calculate the fold changes of mRNA or rRNA levels
and normalized to GAPDH mRNA. Average results from 3
independent experiments were shown as mean 6 SD.
Colony assay and soft agar assay
Colony assay was performed as previously described [6]. Briefly,
1,000 cells were seededin100-mm plates intriplicate and incubated
for2 weekstoallow coloniestoform.Thenthemediawereremoved
and the colonies were stained with methylene blue solution (50%
methanol and 0.5% methylene blue) at room temperature for
5 minutes. The plates were rinsed with water and colony number
was counted. For soft agar assay, cells were seeded at a density of
10,000 cells per well in 6-well cell culture plate in 2 ml 0.33% agar
and cultured for 14 days at 37uC and 5% CO2. Colonies were then
stained with 0.05% crystal violet overnight at 4uC by cover the soft
agar with 1 ml of dye. Colonies were counted in the entire well.
Cell survival, apoptosis, and cell cycle assay
Cell survival was measured by MTT (3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) assay as previously described [24].
For apoptosis assay, Caspase-Glo 3/7 Assay was used according to
the manufacturer’s instructions (Promega). Apoptosis was also
measured by Annexin V staining and flow cytometry (FACScan,
Becton Dickinson, San Jose, CA) or by proprion iodine staining and
flow cytometry according to the manufacturer’s instructions. Cell
cycle was measured by flow cytometry after proprion iodine staining.
Scratch assay
Cells were grown in 6-well plates until confluence was reached.
Then, a gap was made by scratching the cells with a 200-ul pipette
tip. Cell migration into the gap was observed and imaged over
time.
Cell migration assay
Cellswerecultured ina Transwell culture system.Cell culture top
chamber with 8.0 mm pore size filter (BD Labware, Le Pont De
Claix, France) was inserted into a 24-well plate (bottom chamber).
500 ml keratinocyte medium supplemented with EGF containing
10% FBS was added to the bottom chamber. 10
5 cells were seeded
in 100 ml keratinocyte serum- free medium in the top chamber.
Cells were culture for 48 hours before the medium in the top
chamber was siphoned off and moved to the bottom chamber
containing 4% paraformaldehyde to fix cells for 10 minutes. Top
chamber was rinsed in PBS and inverted for staining. 50 mlo f5 %
crystal violet in 25% methanol was applied onto the bottom of the
filter of the top chamber and cells were stained for 10 minutes.
Excess crystal violet was washed off by plunging the top chamber
into distilled water in a beaker several times. Finish washing in a
second beaker till water is clear. Cells on top side of filter (cell that
did not migrate) were removed using a moist cotton swab. The filter
was then air dried. Cells were counted at 406magnification in 5–7
fields under an inversion microscope.
Crystal violet staining
Cells cultured on cover slips were fixed in 4% paraformalde-
hyde for 10 min. Cover slip was rinsed with PBS once and covered
with 0.5% crystal violet (Sigma-Aldrich, St. Louis, MO) in 20%
methanol for 10 min. Then the cover slip was rinsed with water 3
times. The stained cover slip was mounted on a regular glass slide
with KPL mounting medium (Gaithersburg, MD). All steps were
carried out at room temperature.
3D culture of HPDE cells
3D culture of HPDE cells was performed as previously
described [25]. Briefly, we added 40 ul of Growth Factor Reduced
Matrigel (BD Biosciences, San Jose, CA) to each well of an 8-well
glass chamber slide and let it solidify at 37uC. Then, we added, on
top of the Matrigel bed, 5,000 cells/well in 400-ul keratinocyte
serum- free medium supplemented with EGF and bovine pituitary
extract containing 2% Matrigel. We grew the cells in a 5% CO2
humidified incubator at 37uC. After 2 weeks, using laminin V
antibody, we performed immunofluorescent analysis followed by
confocal microscopy, as previously described [25].
Knockdown of endogenous eIF3f and hnRNP K
Endogenous eIF3f was stably knocked down using 5 prede-
signed MISSION eIF3f shRNA lentiviral particles (NM_003754),
according to the manufacturer’s instructions (Sigma-Aldrich). Pre-
designed hnRNP K siRNA (sense: 59- ggaacaagcauuuaaaaga-39,
antisense: 59-ucuuuuaaaugcuuguucc-39) or negative control siRNA
(50 nM) (Eurogentec, San Diego, CA) were transfected into the
cells using Lipofectamine 2000 (Invitrogen), according to the
manufacturer’s instructions.
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PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e34194Figure 1. eIF3f-silencing in normal pancreatic epithelial cells led to malignant transformation. (A) In HPDE cells, eIF3f-silenced cells had a
higher proliferation rate. Same number of eIF3f stable knockdown (clone #5) and control HPDE cells (5610
4 cells/plate) were seeded in triplicate on
100-mm plates and total cell numbers were counted every 2–3 days. (B) eIF3f-silenced cells formed more colonies. Same number (1000 cells) of eIF3f
stable knockdown and control HPDE cells were seeded on 100 mm plates and colony formation was measured after 14 days. (C–E) eIF3f-silenced cells
migrated faster than control cells. Confluent eIF3f RNAi or control RNAi HPDE cells were used for a scratch assay and pictures were taken at the
indicated time as described in Materials and Methods (C). Same cells were also used for a migration assay using a Transwell culture system as
described in Materials and Methods. A representative picture of the migrated cells stained with crystal violet on the filter was shown (D). Average
number of migrated cells were counted and statistic difference between 2 cell lines was shown (E). (F) eIF3f-silenced cells were more resistant to
apoptosis. eIF3f or control RNAi HPDE cells were treated with staurosporine (10 ng/ml) (ST) to trigger apoptosis. Apoptosis was measured after 24 h
for ST using Annexin V staining and flow cytometry. Percentage of apoptotic cells out of total cells from 3 independent experiments was shown. (G)
eIF3f-silenced cells were more resistant to gemcitabine treatment. eIF3f or control RNAi HPDE cells were treated with different concentrations of
gemcitabine for 24 h before measuring the cell survival by MTT assay. The average ratio of gemcitabine/vehicle-treated cells OD from 3 independent
experiments was plotted against gemcitabine concentrations.
doi:10.1371/journal.pone.0034194.g001
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Immunoprecipitation and Western blotting was performed as
previously described [8]. The eIF3f antibody that we used was
raised in a goat as previously described [8]. The CDK11 antibody
was raised in a rabbit as previously described [8]. We purchased
the hnRNP K monoclonal and a-tubulin antibody from Sigma-
Aldrich and the cyclin B1 antibody from Santa Cruz Biotechnol-
ogy.
Figure 2. eIF3f-silencing led to increased cell size, nuclear pleomorphism, aneuploidy, and cell cycle abnormality. (A) eIF3f-silenced
cells had an increased cell size. Two proliferating eIF3f-silenced clones (#4 and #5) and a control RNAi HPDE cell line were harvested and
resuspended at 1610
6/ml in PBS solution. Cell sizes (indicated by forward scatter wave length-FSC) were measured by flow cytometry. (B) eIF3f-
silenced cells had increased tetraploidy, increased number of G2/M phase cells, and decreased apoptosis. Cell cycle and apoptosis (indicated by sub-
G1 peak) of 2 different eIF3f-silenced clones and a control RNAi HPDE cell line were measured by propion iodine staining and flow cytometry.
Percentages of the indicated cells out of total cells were listed. (C) eIF3f-silencing produced increased binucleated/multinucleated cells (arrows). eIF3f-
silenced cells and control HPDE cells were stained by crystal violet or DAPI. Representative images were shown. (D) Binucleated cells were counted in
2 different eIF3f-silenced clones and a control cell line. Average percentage of binucleated cells out of total cells from 3 independent experiments
was shown.
doi:10.1371/journal.pone.0034194.g002
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Immunohistochemistry analysis was performed as previously
described [9]. We substituted regular secondary antibody with
biotinylated secondary antibody and streptavidin-conjugated Qdot
655 (Tissue Acquisition and Cellular/Molecular Analysis Shared
Service-TACMASS, University of Arizona Cancer Center). The
nuclei were stained with DAPI in mounting medium.
Coimmunoprecipitation and LC-MS-MS assay
Cell lysates were prepared from control and anti-Fas-treated
A375 cells, then immunoprecipitated with eIF3f-specific antibody.
Next, the immunocomplexes were subjected to 2-dimensional (2D)
SDS-PAGE. Any protein spots on the anti-Fas-treated cell
immunocomplex gel that appeared different from the control gel
were cutted and submitted for digestion and proteomic analysis,
Figure 3. eIF3f-silenced HPDE cells showed malignant features in 3D culture and soft agar assay. (A) Control and eIF3f-silenced HPDE
cells were stably transduced with a GFP-expressing lentivirus (pLKO-puro CMV-TurboGFP, Sigma-Aldrich) and positive cells were sorted by a cell
sorter (FACSAria) (Fig. S3). These GFP-expressing cells were used in an ex vivo 3D- cell culture system, immunofluorescent and confocal microscopy
analysis. Laminin V (indicating basement membrane) was labeled with laminin V antibody and secondary antibody conjugated with Texas Red. A
representative picture of our 3D cell culture system is shown. Note the loss of normal architecture, of cellular polarity, and of smooth basement
membrane in eIF3f-silenced HPDE cells. Bar: 50 mm. (B) We counted regular sphere and irregular structures of control cell lines and 2 eIF3f-silenced
HPDE cell lines after 10 days of 3D culture. Note that eIF3f-silenced cells formed much more irregular structures than control cells. (C) Soft agar assay:
control and eIF3f-silenced HPDE cells were seeded at a density of 10000 cells per well in 6-well plate in 2 ml 0.33% agar and cultured for 14 days.
Colonies were stained with 0.05% crystal violet overnight at 4uC. Colonies in the entire well were counted. Representative images of colonies and
histogram is shown.
doi:10.1371/journal.pone.0034194.g003
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previously described [26].
Statistical analysis
All data are reported as mean 6 standard deviation (SD). When
appropriate, differences between 2 groups were compared by the t
test. Differences were considered significant at P,0.05.
Results
Decreased eIF3f expression leads to malignant
transformation of normal epithelial cells
Using quantum dot (Qdot)-labeled eIF3f antibody, we demon-
strated that eIF3f was markedly decreased in pancreatic adenocar-
cinomatissue,ascomparedwithnormalpancreaticducts(Fig.S1A).
Restoration of eIF3f expression in BxPC3 and MiaPaCa-2
pancreatic cancer cells induced apoptosis (Fig. S1B). However, it
is unclear whether decreased eIF3f expression was the cause, rather
than the consequence, of malignant transformation. To further
investigate whether decreased eIF3f expression can transform
normal epithelial cells, we stably knocked down endogenous eIF3f
expression in the immortalized normal human pancreatic ductal
epithelial (HPDE) cells, using 5 different eIF3f shRNA lentiviral
transduction particles (Sigma-Aldrich) (Fig. S2A). HPDE cells are
the only available immortalized human pancreatic ductal epithelial
cell line that expresses normal level of eIF3f. They resembled the
phenotype of normal cells rather than cancerous cells in vivo [27].
The proliferation of HPDE cells is anchorage-dependent, and they
are not tumorigenic in SCID mice. We demonstrated that eIF3f
mRNA was stably knocked down by 58% to 92% and eIF3f protein
Figure 4. eIF3f inhibited both cap-dependent and IRES-dependent translation. (A) The map of the pRF bicistronic luciferase reporter
(Renilla luciferase [Rluc], Firefly luciferase [Fluc]) constructs contained 1 of the 2 IRES elements of EMCV or HCV. (B) Same number of control and eIF3f-
silenced HPDE cells were transfected with the same amount of 1 of the pRF bicistronic luciferase constructs. Dual luciferase assay for both firefly and
renilla luciferase activity was performed 24 hours after transfection according to the manufacturer’s instructions (Promega). Relative luciferase activity
compared to control RNAi cells from 3 independent experiments was shown. (C) Control and eIF3f-silenced HPDE cells were either asynchronous or
treated with nocodazole (40 ng/ml) for 16 h to block the cells in G2/M phase. Cells were harvested and Western blot was performed using CDK11,
cyclin B1 and vinculin antibodies. Note that CDK11
p58 expression was present only in mitotically synchronized control cells, but was also present in
asynchronous eIF3f-silenced cells because of increased IRES activity in its 59UTR. Cyclin B1 expression confirmed the G2/M phase. Vinculin was used as
loading control. (D) Starvation led to increased eIF3f protein level. HFF-1 and HPDE cells either were cultured in regular medium or were starved for
6 hours in PBS before harvest. Western blot is performed to determine eIF3f protein level. Densitometric analysis of the eIF3f bands normalized to
corresponding a-tubulin is shown at the bottom.
doi:10.1371/journal.pone.0034194.g004
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representative clone #5 or clone #4 and #5 were used unless
otherwise stated. Stable knockdown of eIF3f in the HPDE cells
increased cell proliferation, clonogenicity, apoptotic resistance,
survival, resistance to a chemotherapy drug (gemcitabine), mesen-
chymal morphology, and migration (Fig. 1, Fig. S2B–D). Moreover,
eIF3f-silenced cells also showed increased cell size, nuclear
pleomorphism, aneuploidy, and cell cycle abnormality (Fig. 2).
Note that increased cell size and aneuploidy caused by aberrant
cytokinesis have been reported to be associated with aberrantly
increased translation [28]. These features are supportive of
malignant transformation in eIF3f-silenced HPDE cells.
Cells behave differently in 2-dimensional culture system versus
3-dimensional (3D) culture system. Malignant features of tumor
tissue in vivo that distinguish from normal tissue include disrupted
normal architecture and loss of polarity. To further confirm
Figure 5. eIF3f induced rRNA degradation in pancreatic cells. (A) Restoration of eIF3f expression in pancreatic cancer cells decreased the
rRNA level. MiaPaCa-2 cells were transfected with pcDNA3-eIF3f or pcDNA3. Relative fold changes of rRNA and eIF3f levels were quantified by real
time RT-PCR and normalized to GAPDH mRNA. (B)(C) Silencing of eIF3f expression increased the rRNA level during apoptosis. Control and eIF3f-
silenced HPDE cells were treated with DMSO vehicle control or etoposide (10 mM) for indicated time to induce apoptosis. Cells were harvested and
total RNA was isolated using RNeasy Kit. Relative fold changes of 28S (B) and 18S (C) rRNA levels were quantified by real time RT-PCR after DNase
treatment. (D) Time course of cell survival after etoposide treatment. HPDE cells were treated with DMSO or etoposide (10 mM) for indicated time. Cell
survival was measured using MTT assay. Relative percentages of survived cells compared to DMSO-treated cells were shown. (E) Silencing of eIF3f
expression attenuated rRNA degradation. Control and eIF3f-silenced HPDE cells were treated with actinomycin D (0.5 mg/ml) to block transcription for
3, 6 and 8 h before harvest. Total RNA was isolated, treated with DNase, and relative 28S and 18S rRNAs fold changes compared to control were
quantified by real time RT-PCR and normalized to GAPDH mRNA.
doi:10.1371/journal.pone.0034194.g005
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for the indicated time and cell fractionation was performed as previously described [17]. 500 mg of the lysates from the soluble (S) and pellet (P)
fractions of the cells were immunoprecipitated with IgG or hnRNP K antibodies, followed by immunoblot with eIF3f and hnRNP K antibodies (top 2
panels). 50 mg of the same lysates were used for immunoblot with eIF3f, hnRNP K and a-tubulin antibodies without immunoprecipitation (bottom 3
panels). (B) HPDE cells were treated with DMSO or etoposide (Eto) (10 mM) for 24 hours. Cell lysates were immunoprecipitated with IgG or eIF3f
antibodies, followed by immunoblot with eIF3f and hnRNP K antibodies (left 2 panels). The intensities of the bands were quantified using ImageJ
software. The same cell lysates were used for immunoblot with eIF3f, hnRNP K and vinculin antibodies without immunoprecipitaiton (right 3 panels).
(C) Immunofluorescent staining to eIF3f (FITC, green) and hnRNP K (Cy3, red) in HFF-1 fibroblasts treated with sodium arsenite (0.5 mM) for
30 minutes. (D) eIF3f directly interacted with hnRNP K. The left diagram shows full-length eIF3f and the location of the Mov34/JAB_MPN domain.
Four GST-eIF3f truncation mutants were designed to localize the binding site of eIF3f with hnRNP K. GST pull-down assay was performed as described
in the Materials and Methods.
doi:10.1371/journal.pone.0034194.g006
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PLoS ONE | www.plosone.org 10 March 2012 | Volume 7 | Issue 3 | e34194whether silencing of eIF3f transforms normal cells growing in a 3D
environment mimicking in vivo situation, we used an ex-vivo 3D-
cell culture system. We showed that eIF3f-silenced HPDE cells
formed more (45–59% vs. 17% in control) irregular masses with
abnormal architecture and polarity (recapitulating malignant
tumors in vivo), while control cells developed into a single-layer
epithelial hollow spheres (resembling normal pancreatic ductal
structure in vivo) (Fig. 3A–B, Fig. S3). Furthermore, eIF3f-silenced
HPDE cells proliferated in an anchorage independent manner by
soft agar assay (Fig. 3C). These results support the hypothesis that
decreased expression of eIF3f is an important cause of pancreatic
cancer.
eIF3f inhibits both cap-dependent and IRES-dependent
translation
Translation initiation can be cap-dependent or cap-indepen-
dent/IRES-dependent. Whether eIF3f inhibits cap-dependent or
cap-independent translation is not known. To investigate the
specific effect of eIF3f on translation, we measured both cap-
dependent and cap-independent/IRES-dependent translation in
eIF3f-silenced HPDE cells using a commonly used bicistronic
luciferase reporter construct that contains both cap structure and
one of the 2 viral IRES elements (EMCV or HCV) (kindly
provided by Dr. Davide Ruggero, UC San Francisco) that require
eIF3 (Fig. 4A) [28,29]. Cap-dependent translation is indicated by
Renilla luciferase activity (Rluc), and IRES-dependent translation
is indicated by Firefly luciferase activity (Fluc). In our study,
silencing of eIF3f increased both cap-dependent and IRES-
dependent translation (up to 2.5-fold increase), indicating a
suppressive role of eIF3f on both translation initiation mechanisms
(Fig. 4B). The variation between the effect of eIF3f-silencing on
EMCV and HCV IRES function can be explained by the different
requirement of translation initiation factors: EMCV IRES requires
eIF4G and eIF4A while HCV IRES does not.
An accurate IRES-dependent translation is required for mitotic
progression [28]. For example, IRES-dependent translation of a
CDK11 isoform (CDK11
p58) facilitates accurate mitotic progres-
sion [30,31]. In our study, we found that CDK11
p58 expression
was markedly increased in asynchronous eIF3f-silenced cells, as
compared with control cells (Fig. 4C). This result was not due to an
unequal mitotic rate, because cyclin B1, a mitotic enrichment
indicator, was equally expressed at a low level in both
asynchronous cells (Fig. 4C). Rather, eIF3f was required for the
suppression of IRES-dependent translation, which, when im-
paired, results in the cytokinesis defect represented by increased
binucleated and mitotic cells in eIF3f-silenced cells (Fig. 2). The
function of eIF3f in inhibition of translation was also supported by
our observation that starvation caused an increase in the eIF3f
level, in both primary fibroblast cells and pancreatic epithelial cells
(Fig. 4D). Starvation was known to lead to the inhibition of
translation. In starved muscle myotubes, however, others have
reported an association between suppressed translation leading to
hypotrophy and a decreased eIF3f level, suggesting a tissue-specific
role of eIF3f [6,32,33].
eIF3f promotes rRNA degradation
We found that restoration of eIF3f expression in pancreatic
cancer cells led to decreased rRNA, especially 28S rRNA (Fig.
S4A). MiaPaCa-2 pancreatic cancer cell line has a decreased
eIF3f expression [6], therefore was used in the following eIF3f-
restoration experiments. Quantitative real time RT-PCR has
been used to quantify rRNA or pre-rRNA level [22,34,35,36]. In
our study, quantification of the rRNA level by real time RT-
PCR showed that 28S and 18S rRNA decreased up to 70% in
eIF3f-restored MiaPaCa-2 pancreatic cancer cells (Fig. 5A, S4A).
This rRNA decrease was not a result of apoptosis, because a
significant rRNA decrease started as early as 4 hours after
transfection, which occurred much earlier than the peak
apoptosis (after 48 hours) (Fig. S4B, C). These results are
consistent with our previous rRNA degradation observations in
melanoma cells [6].
To further rule out the apoptosis effect on rRNA level and to
assess if decreased eIF3f expression does the opposite, we used
eIF3f-silenced HPDE cells to access rRNA level change during
apoptosis. We found that the rRNA level was markedly higher in
eIF3f-silenced cells than in control cells, by more than a 6-fold
increase at 72 hours (Fig. 5B, C). Time course of the cell death was
shown in Fig. 5D. To further prove that this higher level of rRNAs
was due to decreased rRNA degradation rather than increased
rRNA production, we used actinomycin D to block transcription
and then followed the rRNA degradation over time course.
Consistent with our previous observations, silencing of eIF3f
markedly protected rRNA from degradation (up to 4-fold higher)
(Fig. 5E). These results suggested that eIF3f may play an important
role in regulating rRNA degradation.
eIF3f directly interacts with hnRNP K
To define the mechanism by which eIF3f degrades rRNA, we used
a proteomic approach to identify proteins associated with eIF3f. We
found that hnRNP K was one of the prominent proteins associated
with eIF3f during apoptosis (data not shown). Three-hybrid screens
and RNA pull-down assays suggested that hnRNP K binds to 18S
Figure 7. eIF3f regulated rRNA stability through hnRNP K. (A)(B) Endogenous hnRNP K bound to rRNA. RIP-RT-PCR analysis was performed in
HPDE cells using IgG control or hnRNP K-specific antibodies as described in Materials and Methods. hnRNP K-binding rRNA was immunoprecipitated
and eluted from the beads. Regular RT-PCR or PCR (without [w/o] RT as a negative control) (A) or quantitative real time RT-PCR (B) was used to
identify the relative quantity of hnRNP K-binding rRNA. Input is the RT-PCR of the total RNA before immunoprecipitation as a positive control. IgG is
the RT-PCR of the non-specific RNA that immunoprecipitated with the same species IgG antibody as a negative control. In (B), immunoprecipitated
rRNA was normalized against total input rRNA for the same sample. (C) Ectopic expression of hnRNP K protected rRNA from degradation. HPDE cells
were transfected with pcDNA4-hnRNP K or pcDNA4 control vector. Cells were treated with actinomycin D for 3 or 8 hours to block transcription
24 hours after transfection. Real time RT-PCR analysis was performed to quantify rRNA fold change normalized to GAPDH mRNA. (D) Silencing of
hnRNP K decreased rRNA. Predesigned hnRNP K siRNA (50 nM, Eurogentec) was transfected into MiaPaCa-2 cells using Lipofectamine. rRNA and
hnRNP K mRNA fold changes compared to control RNAi cells were assessed by real time RT-PCR after 48 hours. (E)(F) Increased rRNA degradation in
hnRNP K-silenced cells. hnRNP K expression was knocked down in MiaPaCa-2 cells by siRNA as in (D). Actinomycin D was added to the cells 48 hours
after transfection for 3 or 8 hours before harvest. Total RNA was isolated, DNase treated and real time RT-PCR analysis was performed to quantify 28S
(E) and 18S (F) rRNA fold changes normalized to GAPDH mRNA. (G)(H) rRNA degradation was associated with decreased binding of hnRNP K with
rRNA during apoptosis. HPDE cells were treated with etoposide (10 mM) for 24, 48 or 72 hours and hnRNP K-bound 28S rRNA (G) and total 28S rRNA
(H) were assessed by RIP and/or real time RT-PCR assay. The fold changes of 28S rRNA were normalized to total input RNA (G) or GAPDH mRNA (H). (I)
Silencing of eIF3f expression increased the binding of hnRNP K to rRNA. RIP-RT-PCR was performed in eIF3f-silenced or control HPDE cells using IgG
or hnRNP K antibodies to assess the 28S rRNA level that binds to hnRNP K. The relative fold changes of hnRNP K-bound 28S rRNA was normalized to
total input rRNA of the same sample.
doi:10.1371/journal.pone.0034194.g007
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PLoS ONE | www.plosone.org 11 March 2012 | Volume 7 | Issue 3 | e34194Figure 8. Localization of eIF3f/hnRNP K and their relationships with P body and stress granule. HPDE or HFF-1 cells were treated with
sodium arsenite (0.5 mM) for 45 minutes to trigger P bodies and stress granules formation. (A)(B) Under stress, eIF3f was predominantly co-localized
with both P bodies and stress granules. Immunofluorescent study was performed using eIF3f, P body markers (Rck, Dcp1a), or stress granule marker
eIF4G antibodies and FITC (green) or Texas Red (red) -tagged fluorescent secondary antibodies in HPDE cells. Arrowhead indicated co-localization foci
eIF3f and hnRNP K Regulate rRNA Stability
PLoS ONE | www.plosone.org 12 March 2012 | Volume 7 | Issue 3 | e34194and 25S rRNA in yeast [15]. However, whether hnRNP K regulates
rRNA degradation in human is not known. Using co-immunopre-
cipitation analysis, we confirmed that endogenous eIF3f increased its
interaction with hnRNP K during apoptosis in 2 different cell lines
(Fig. 6A, B). We can also show that endogenous eIF3f was co-
localized with hnRNP K in cytoplasmic foci in cells under stress
(Fig. 6C, S5A). Furthermore, recombinant eIF3f directly interacted
with in vitro transcribed and translated hnRNP K (Fig. 6D).
Previously, we showed that the Mov34/JAB_MPN domain of eIF3f
was involved in protein-protein interaction [8]; in our current study,
we showed that this domain also mediated the interaction between
eIF3f and hnRNP K (Fig. 6D). These results suggested a direct
interaction between eIF3f and hnRNP K.
hnRNP K binds to and stabilizes rRNA
To determine the function of hnRNP K in regulating rRNA
degradation, we first performed RIP-RT-PCR analysis to assess
whether hnRNP K binds to rRNA. We found that endogenous
hnRNP K protein co-immunoprecipitated with rRNA in HPDE
cells, indicating that hnRNP K bound to both 28S and 18S rRNA
(Fig. 7A, B). To investigate whether hnRNP K protects rRNA
from degradation, we ectopically expressed hnRNP K and
observed rRNA degradation over time after blocking de novo
transcription using actinomycin D. Increased hnRNP K expres-
sion dramatically protected rRNA from degradation (more than 4-
fold) (Fig. 7C, S5B). In contrast, suppressed hnRNP K expression
in MiaPaCa-2 pancreatic cancer cells significantly reduced the
rRNA level and increased rRNA degradation (up to .60%
decrease) (Fig. 7D–F, S5C). We have shown previously that
hnRNP K was successfully knocked down in MiaPaCa-2 cells [23].
MiaPaCa-2 pancreatic cancer cells were chosen because we have
reported that hnRNP K expression is increased in this cell line
[23]. These results suggested, for the first time to our knowledge,
that hnRNP K is essential and sufficient for the maintenance of
rRNA stability in human epithelial cells.
To further investigate whether the binding of hnRNP K to
rRNA correlates with rRNA degradation, we examined its binding
to 28S rRNA using RIP-RT-PCR analysis during apoptosis. We
saw a more than 50% decrease in hnRNP K-associated 28S rRNA
at 48 and 72 hours after etoposide (Eto) treatment (Fig. 7G), which
correlated with the time course of 28S rRNA degradation and cell
death (Fig. 7H, S5D). These results suggested that dissociation of
hnRNP K from rRNA may contribute to rRNA degradation
during apoptosis.
eIF3f interferes with the rRNA-protective function of
hnRNP K
We found that hnRNP K protected rRNA from degradation,
whereas eIF3f promoted rRNA degradation. We also showed that
eIF3f interacted with hnRNP K during apoptosis. Thus, we
hypothesize that eIF3f may promote rRNA degradation by
interfering with the rRNA protective function of hnRNP K. To
investigate this hypothesis, we compared the rRNA-binding
capacity of hnRNP K in eIF3f-silenced HPDE cells and control
cells. Indeed, silencing of eIF3f increased the binding of hnRNP K
to 28S rRNA by more than 9-fold (Fig. 7I). This result supported
our hypothesis that eIF3f interferes with the rRNA protective
function of hnRNP K.
Subcellular localization of eIF3f, hnRNP K, and rRNAs and
their relationships with P bodies and stress granules
Currently, it is not known where and how normal human rRNA
is degraded during stress. Yeast nonfunctional rRNA decay is seen
in P bodies and perinuclear foci [37]. Human translational stalled
mRNAs were observed in P bodies (which generally contain the
mRNA decay machinery), as well as in stress granules (which
contain many translation initiation components, including eIF3).
To determine the subcellular localization of eIF3f/hnRNP K and
their relationships with P body and stress granule, we used arsenite
stress to induce P body and stress granule formation. We found
that eIF3f was colocalized with P-body markers (Rck, Dcp1a) in
91% of the cytoplasmic foci of arsenite-stressed HPDE cells [38]
(Fig. 8A, S6A, S7A, S7E). We observed this phenomenon not only
in normal HPDE cells, but also in BxPC3 pancreatic cancer cells
(Fig. S6A). Such a surprising result challenges the current
assumption that eIF3 only localizes to stress granules [38]. Our
disparate result is probably due to the overlooked specific
individual subunits of eIF3, such as eIF3f in our study. Not
surprisingly, we found that eIF3f was also co-localized with stress
granule marker eIF4G in 84% of the cytoplasmic foci (Fig. 8B,
S7B). In addition, eIF3f accumulated to noticeable cytoplasmic
and perinuclear foci that were not P bodies or stress granules
(Fig. 8B, 8C, S6A–B, arrowheads). These results suggested that
eIF3f is localized in both P bodies and stress granules, as well as in
unknown cytoplasmic foci. Furthermore, eIF3f-silenced cells have
up to 2.5-fold increase in P-body-bearing cells, suggesting that
eIF3f may inhibit P body formation (Fig. S6C).
We also assessed the cellular localization of hnRNP K (in
parallel with eIF3f) and its relationship with P bodies, stress
granules, and perinuclear foci in HFF-1 and HPDE cells under
stress. Other studies have shown that hnRNP present in both P
bodies and stress granules [39]. However, our data suggested that
hnRNP K was localized predominantly in stress granules (83% in
HFF-1 cells and 99% in HPDE cells) (Fig. 8D, S6D, S7C, S7F)
and in a few unknown cytoplasmic foci (Fig. 8E, arrow), but not in
P bodies (0% in both cell lines) (Fig. 8E, S6E, S7D, S7G) [40].
Therefore, the interaction between eIF3f and hnRNP K may take
place in stress granules or in other cytoplasmic foci, but not in P
bodies. The quantification of the signals is shown in Fig. S7.
To investigate the association of eIF3f/hnRPN K with rRNAs,
we combined immunofluorescent and molecular beacon assay
[41]. In unstressed cells, we found that most of the 28S and 18S
rRNA was perinuclear, with some rRNA in the nucleoli as
expected (Fig. 9A, B). In the perinuclear region and in some
cytoplasmic foci, eIF3f was partially co-localized with 18S and 28S
rRNA (Fig. 9A, B, arrows). Under arsenite-induced stress, rRNA
spread away from the nucleus, and 18S rRNA tended to
accumulate into bigger cytoplasmic or perinuclear foci, but 28S
rRNA was more diffused (Fig. 9A, B). As well, eIF3f also tended to
accumulate into cytoplasmic foci where it was mostly co-localized
with 18S, and partially with 28S rRNA (Fig. 9A, B), suggesting
that the degradation mechanisms of 28S and 18S rRNA may be
different, as shown in the nonfunctional rRNA degradation in
yeast [37]. In unstressed cells, hnRNP K was partially co-localized
with rRNA in the perinuclear region, but then accumulated into
cytoplasmic foci (mostly stress granules) that were mostly not co-
localized with rRNA in stressed cells (Fig. 9C, D). These results
(yellow). Arrow indicated non-P body, non-stress granule foci. (C) eIF3f was also localized to non-P body, non-stress granule perinuclear foci (arrow) in
HPDE cells. Same experiments as (A) were performed. (D)(E) hnRNP K was localized in stress granules and unknown cytoplasmic foci (arrow), but not
in P bodies. Immunofluorescent study was performed using hnRNP K (mouse), Rck (rabbit), or eIF4G (goat) antibodies and FITC-tagged anti-mouse
(green), Texas Red-tagged anti-rabbit (red) or Cy3-tagged anti-goat secondary antibodies (red) in HFF-1 cells. Bar: 10 mm.
doi:10.1371/journal.pone.0034194.g008
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PLoS ONE | www.plosone.org 13 March 2012 | Volume 7 | Issue 3 | e34194Figure 9. rRNA was accumulated in non-P body, non-stress granule cytoplasmic foci during stress. (A) eIF3f was partially co-localized
with 28S rRNA in cytoplasmic foci. HFF-1 cells were treated with sodium arsenite for 45 minutes and labeled with 28S rRNA molecular beacon (FAM-
tagged, green) followed by immunofluorescent analysis using eIF3f antibody (Texas Red-tagged secondary, red). (B) eIF3f was mostly co-localized
with 18S rRNA in cytoplasmic foci in stressed cells. HFF-1 cells were treated with sodium arsenite for 45 minutes and labeled with 18S rRNA molecular
beacon (FAM-tagged, green) followed by immunofluorescent analysis using eIF3f antibody (Texas Red-tagged secondary, red). (C) (D) hnRNP K was
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hnRNP K to rRNA was associated with increased rRNA
degradation in stressed cells (Fig. 7). We further showed that
rRNA was not co-localized with P bodies, but may be partially co-
localized with Dcp1a diffusely in the perinuclear region (Fig. S8).
Thus, rRNA degradation appears to occur in non-P body, non-
stress granule cytoplasmic foci. eIF3f may play an important role
in rRNA degradation by undermining the protective function of
hnRNP K to rRNA.
Discussion
We previously described decreased expression of eIF3f in
pancreatic cancer [6,9]. One of the molecular mechanisms of the
decreased expression of eIF3f is loss of heterozygosity [9]. Other
possible causes are mutation, epigenetic and transcription factor
regulations (unpublished data by our group). We also previously
showed that ectopic expression of eIF3f inhibited cell growth and
induced apoptosis [6]. However whether decreased eIF3f can
transform normal cells is unknown. In our current study, we
further demonstrated that decreased eIF3f expression transformed
a normal pancreatic epithelial cell line. Interestingly, decreased
eIF3f expression also seemed to account for drug resistance in
chemotherapy.
In the literature, some evidence suggests that alterations in eIF3
can contribute to tumorigenesis. Aberrant mRNA and protein
levels of several eIF3 subunits have been detected in several
different solid tumors and in several different cancer cell lines.
Most eIF3 subunits (a, b, c, h, and i) are oncogenic. Interestingly,
reduced expression and loss of heterozygosity (LOH) of eIF3e have
been found in human breast cancer and lung cancer [42]. Clearly,
deregulation of eIF3 subunits can contribute to tumorigenesis.
We previously showed that eIF3f is a negative regulator of
translation [6]. Other investigators have observed a significant
inhibition of overall protein synthesis in various cell types when
cells are committed to apoptosis [43,44,45]. This downregulation
of protein synthesis may either activate apoptosis or protect cells
against noxious agents and ensure the conservation of resources
needed for survival [46]. One of the 6 hallmarks of cancer is
evading apoptosis [47]. Loss of eIF3f in pancreatic cancer may
contribute to tumor cells’ evading apoptosis via upregulation of
protein synthesis. Another important mechanism for tumorigenesis
is mitotic defect. As shown in our current study, misregulation of
translation by eIF3f can cause aberrant cytokinesis and aneuploidy
because of altered IRES-dependent translation. The mechanism
by which eIF3f regulates protein synthesis is multileveled. One
possible mechanism is direct binding and interference of the
function of eIF3 translation initiation complex [17]. Another
possible mechanism is further explored in the current paper –
regulation of rRNA degradation and thus ribosome function. It is
also very reasonable to suspect that eIF3f may directly or indirectly
bind to mRNAs, since the eIF3 complex and some of the subunits
of eIF3 is known to bind to mRNAs. Currently, whether the effect
of eIF3f is universal and/or more specific for certain genes is not
known. Studies are undergoing in our laboratory using RNA
immunoprecipitation and microarray analysis to globally search
for specific eIF3f-binding RNAs. The hope is to determine which
coding and non-coding RNAs or consensus RNA sequence eIF3f
binds to in order to find a potential pattern.
One of the mechanisms of translation inhibition by eIF3f may
be eIF3f-induced degradation of rRNA [6]. Exactly how eIF3f
induces rRNA degradation is unclear. In our current study, we
found evidence suggesting that eIF3f regulates rRNA degradation
by interacting with hnRNP K, an RNA-binding protein. Our data
support a model (Fig. 10) in which eIF3f sequesters hnRNP K to
inhibit it’s binding to rRNA, which leads to increased rRNA
degradation and attenuated translation. In tumor cells, loss of
eIF3f leads to increased binding of hnRNP K to rRNA, as well as
imbalanced rRNA homeostasis and translation. The rRNA
synthesis and degradation in a cell needs to be perfectly balanced
in order to maintain homeostasis of protein synthesis. An increased
rRNA level either through increased rRNA synthesis or through
decreased rRNA degradation can be potentially oncogenic [11].
The regulatory mechanism of rRNA degradation in mammals is
still not well understood; most studies have been carried out in
yeast [37]. Our study demonstrated an unexpected function of a
human translation initiation factor in rRNA degradation, linking
translation initiation to the rRNA degradation mechanism and
shedding light on the molecular mechanisms of the tumorigenic
role of eIF3f in pancreatic cancer.
Currently, we still do not know where and how normal human
rRNA is degraded during various physiologic or pathologic
cellular processes, such as the cell cycle, stress, and apoptosis. In
partially co-localized with rRNA in the perinuclear region in unstressed cells, but accumulated into cytoplasmic foci that were mostly not co-localized
with 28S or 18S rRNA in stressed cells. HFF-1 cells were treated with sodium arsenite for 45 minutes and labeled with 28S or 18S rRNA molecular
beacon (FAM-tagged, green) followed by immunofluorescent analysis using hnRNP K antibody (Texas Red-tagged secondary, red).
doi:10.1371/journal.pone.0034194.g009
Figure 10. Diagram of our hypothesis. hnRNP K normally binds to
and stabilizes rRNA. A physiologic expression level of eIF3f competes
with rRNA for the binding of hnRNP K. This contributes to the
maintenance of the homeostasis of rRNA level and translation in cells.
Increased eIF3f expression contributes to apoptosis via hnRNP K
sequestration and increased rRNA degradation. On the other hand
during tumorigenesis, decreased expression of eIF3f releases more
hnRNP K to bind to rRNA, which leads to increased rRNA stability,
translation and cell growth.
doi:10.1371/journal.pone.0034194.g010
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PLoS ONE | www.plosone.org 15 March 2012 | Volume 7 | Issue 3 | e34194yeast, nonfunctional rRNA decay can be divided into 2
mechanistically distinct pathways [37]; mutated 18S rRNA can
be seen in the P bodies, whereas mutated 25S rRNA (equivalent to
28S rRNA in humans) can be seen in the perinuclear foci in
cytoplasm [37]. In the mRNA degradation mechanisms that have
been primarily studied in the past, translational stalled mRNA
accumulates in 2 types of cytoplasmic foci: P bodies and stress
granules [38]. P bodies and stress granules are dynamic
organizations of cytoplasmic ribonucleoproteins (RNPs) [38].
Translationally repressed mRNA, in conjunction with the mRNA
decay machinery and other translation repressors, accumulates in
P bodies. Stress granules typically contain poly(A)+ mRNA, 40S
ribosomal subunits, eIF4E, eIF4G, eIF4A, eIF4B, poly(A)-binding
protein (PABP), eIF3, and eIF2 [38]. In contrast to the widely held
assumption, our data showed that eIF3f was localized both to P
bodies and to stress granules. This observation suggests that eIF3f
may play a unique role in mRNA degradation, besides its function
in the translation initiation. Our data also suggest that normal
rRNA decay mechanism may be different from nonfunctional
rRNA decay. Under stress, normal rRNA was not localized either
to P bodies or to stress granules. The exact components of the
rRNA decay cytoplasmic foci need to be further investigated.
Supporting Information
Figure S1 Decreased eIF3f expression in pancreatic
cancer and restoration of eIF3f expression in pancreatic
cancer cells induced apoptosis. (A) Hematoxylin and eosin
(H&E) staining and Qdot immunohistochemistry (IHC) was
performed on normal pancreas or pancreatic cancer tissue sections
using eIF3f specific antibody, biotinylated secondary antibody and
streptavidin-conjugated Qdot 655 (red). The nuclei were stained
with DAPI (blue). The slides were evaluated by light and
fluorescent microscopic examination and the representative
images were taken. Note the loss of eIF3f protein (red) in
pancreatic cancer cells. 4006. (B) Restoration of eIF3f expression
induced apoptosis in pancreatic cancer cells. pcDNA3 or eIF3f
transiently transfected BxPc3 and MiaPaCa-2 pancreatic cancer
cells were analyzed for apoptosis by measuring caspase 3/7
activity.
(TIF)
Figure S2 eIF3f-silencing in normal pancreatic epithe-
lial cells led to malignant transformation. (A) Immortal-
ized normal human pancreatic ductal epithelial (HPDE) cells were
transduced with 1 of the 5 predesigned MISSION eIF3f shRNA
lentiviral particles (Sigma-Aldrich) individually, according to the
manufacturer’s instructions; 5 stable colonies were selected by
puromycin resistance. Cells were harvested and total RNA
extracted. 1 ug of RNA from each cell line were reverse-
transcribed and relative eIF3f mRNA fold changes were examined
by real time PCR and normalized to GAPDH mRNA as described
in Materials and Methods. Cell lysates of the 5 cell lines were used
in a Western blot analysis using eIF3f antibody. Vinculin was used
as loading control. Densitometry analysis of the eIF3f bands
normalized to corresponding vinculin is shown at the bottom. (B)
In activated Kras
G12D HPDE cells, eIF3f-silenced cells had a
higher proliferation rate. eIF3f stable knockdown (clone #5) and
control HPDE cells were stably transfected with pcDNA3-
Kras
G12D. Same number of cells (5610
4 cells/plate) was seeded
in triplicate on 100-mm plates and total cell numbers were
counted every 2–3 days. (C) eIF3f-silenced cells had different cell
morphology. Control and eIF3f RNAi HPDE cells were seeded in
6-well plate at about 50% confluent. Phase contrast images were
taken using a digital camera attached to the microscope after 24 h.
Note that the morphology of eIF3f-silenced HPDE cells mimics
mesenchymal cells. (D) eIF3f-silenced cells had higher survival
rate. eIF3f or control RNAi HPDE cells were treated with TNFa
(0.1 mg/ml) to trigger apoptosis. Cell survival was measured at
indicated times using MTT assay. Relative percentage of survival
compared to control cells was shown.
(TIF)
Figure S3 Generation of GFP-expressing HPDE cells in
a 3D-cell culture. (A) (B) eIF3f-silenced HPDE cells were stably
transduced with a GFP lentivirus and positive cells were sorted by
cell sorter. Representative phase contract and fluorescent images
before and after sorting were shown in (A) and flow cytometry
showed 98% of the cells are GFP positive after sorting (B). (C)
These GFP-expressing green cells were used in an ex vivo 3D-
culture system as described in Fig. 3. More representative confocal
microscopy photos comparing control RNAi and eIF3f RNAi
HPDE cells were shown here. Bar: 50 mm.
(TIF)
Figure S4 eIF3f inhibited translation and decreased
rRNAs in pancreatic cancer cells. (A) Restoration of eIF3f
expression decreased rRNAs. MiaPaCa-2 cells were transfected
with pCMV-HA-eIF3f or pCMV-HA. Relative fold changes of
eIF3f mRNA and rRNA levels were quantified by real time RT-
PCR and normalized to G6PD mRNA. (B) (C) rRNA decrease
caused by restoration of eIF3f is prior to peak apoptosis. MiaPaCa-
2 cells were transfected with pcDNA3-eIF3f or pcDNA3. Cells
were harvested at 4, 8 and 16 h after transfection and total RNA
was isolated using RNeasy kit (QIAGEN). rRNAs (2.0 mg) were
separated on an agarose gel and visualized by UV light (B). The
28S rRNA bands were quantified by densitometric analysis and
shown at the bottom. Apoptosis was measured at the indicated
time point after transfection using caspase Glo 3/7 kit (Promega)
according to the manufacturer’s instruction (C).
(TIF)
Figure S5 eIF3f regulated rRNA stability through
hnRNP K. (A) Immunofluorescent staining of eIF3f (FITC,
green) and hnRNP K (Cy3, red) in HFF-1 fibroblasts treated with
staurosporine (10 ng/mL) for 24 h. (B) Ectopic expression of
hnRNP K. HPDE cells were transfected with pcDNA4-hnRNP K
or pcDNA4 control vector. Cells were treated with actinomycin D
for 3 or 8 hours to block transcription 24 hours after transfection.
Real time RT-PCR analysis was performed to quantify relative
hnRNP K mRNA levels normalized to GAPDH mRNA. (C)
hnRNP K expression was knocked down in MiaPaCa-2 cells by
siRNA as in Fig. 7D. Actinomycin D was added to the cells
48 hours after transfection for 3 or 8 hours before harvest. Total
RNA was isolated, DNase treated and real time RT-PCR analysis
was performed to quantify relative hnRNP K mRNA fold change
normalized to GAPDH mRNA. (D) HPDE cells were treated with
etoposide (10 mM) for 24, 48 or 72 hours and cell survival was
assessed by MTT assay. Average percentage change normalized to
DMSO vehicle-treated cells from 3 independent experiments was
shown.
(TIF)
Figure S6 Localization of eIF3f/hnRNP K and their
relationships with P body and stress granule. (A) (B)
HPDE and BxPC3 cells were treated with sodium arsenite
(0.5 mM) for 45 minutes to trigger P body formation. Immuno-
fluorescent study was performed using eIF3f and P body marker,
Dcp1a, antibodies and FITC (green) or Texas Red (red) -tagged
secondary antibodies as indicated. Arrowheads indicated that
eIF3f is localized to non-P body cytoplasmic foci. (C) eIF3f
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PLoS ONE | www.plosone.org 16 March 2012 | Volume 7 | Issue 3 | e34194inhibited P body formation. eIF3f RNAi and control RNAi HPDE
cells were treated with sodium arsenite for 45 or 60 minutes and P
body bearing and nonbearing cells were counted. A total of at least
200 cells were counted for each cell line. Percentage of P body
bearing cells was calculated. Note that eIF3f-silenced cells had 2.5-
fold increased natural occurring P body-bearing cells in untreated
cells. (D)(E) hnRNP K was localized in stress granules, but not in P
bodies. Immunofluorescent study was performed using hnRNP K
(mouse), Rck (rabbit), or eIF4G (goat) antibodies and FITC-tagged
anti-mouse (green), Texas Red-tagged anti-rabbit (red) or Cy3-
tagged anti-goat (red) secondary antibodies in HPDE cells. Bar:
10 mm.
(TIF)
Figure S7 Quantification of immunofluorescent signals.
The fluorescent dot signals (green, orange, red) in the cytoplasm
were counted in the following samples. At least 100 dots were
counted and percentages of each color signal were shown. (A)–(G)
Quantification of fluorescent signals shown representatively in
Fig. 8A and 8C, 8B, 8D, 8E, S6A–B, S6D, and S6E respectively.
(TIF)
Figure S8 rRNA was not co-localized with P body. HFF-1
cells were treated with sodium arsenite for 45 minutes and labeled
with 28S or 18S rRNA molecular beacon (FAM-tagged, green)
followed by immunofluorescent analysis using P body marker
Dcp1a antibody (Texas Red-tagged secondary, red).
(TIF)
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